EUVIMEDEUVIMED entdecken
Crossref

Emerging SARS-CoV-2 Omicron Subvariants in 2025: Clinical Impacts and Public Health Challenges

Md. Islam, No author No author, Abdullah Jaman, Nayma Ahmmed, Al Arbin, Jabedul khondaker, Md. Ali, Md. Islam, Snygdha Das, Badhan Dey, Tanzir Siddiqui, Mahfuza Mubarak

Journal of Biosciences and Public Health · 2025 · 1 (1) · 1

DOI: 10.5455/jbph.2025.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biosciences and Public Health, 2025. Verfasst von Md. Islam und 11 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS-CoV-2 Omicron variant and its subvariants have posed significant challenges to global public health since their emergence in late 2021. This comprehensive review examines the epidemiological trends, clinical impacts, and public health challenges associated with Omicron subvariants, with a focus on high-density populations such as Bangladesh. The review highlights the evolution of Omicron subvariants, including BA.1, BA.2, BA.4/BA.5, XBB, BQ.1, EG.5, and JN.1, emphasizing their increased transmissibility, immune evasion, and varying severity. Despite lower intrinsic severity compared to Delta, Omicron's rapid spread has strained healthcare systems, particularly in regions with limited resources. In Bangladesh, Omicron subvariants such as XFG, XFC, and NB.1.8.1 have driven recent surges, with test positivity rates peaking at 20% in June 2025. The review underscores the persistent threat of these subvariants, especially among vulnerable populations like the elderly, and the critical need for enhanced genomic surveillance, vaccination campaigns, and adaptive public health strategies. Some of the key challenges include vaccine hesitancy, healthcare infrastructure limitations, and socioeconomic barriers. The findings advocate for robust global cooperation, updated vaccines, and targeted interventions to mitigate the ongoing impact of Omicron subvariants in high-risk settings.

Zitieren

APA

Islam, M., author, N. A. N., Jaman, A., Ahmmed, N., Arbin, A., khondaker, J., Ali, M., Islam, M., Das, S., Dey, B., Siddiqui, T., & Mubarak, M. (2025). Emerging SARS-CoV-2 Omicron Subvariants in 2025: Clinical Impacts and Public Health Challenges. Journal of Biosciences and Public Health, 1(1), 1. https://doi.org/10.5455/jbph.2025.06

Vancouver

Islam M, author NAN, Jaman A, Ahmmed N, Arbin A, khondaker J, et al. Emerging SARS-CoV-2 Omicron Subvariants in 2025: Clinical Impacts and Public Health Challenges. Journal of Biosciences and Public Health. 2025;1(1):1. doi:10.5455/jbph.2025.06

BibTeX
@article{Islam2025,
  author = {Islam, Md. and author, No author No and Jaman, Abdullah and Ahmmed, Nayma and Arbin, Al and khondaker, Jabedul and Ali, Md. and Islam, Md. and Das, Snygdha and Dey, Badhan and Siddiqui, Tanzir and Mubarak, Mahfuza},
  title = {Emerging SARS-CoV-2 Omicron Subvariants in 2025: Clinical Impacts and Public Health Challenges},
  journal = {Journal of Biosciences and Public Health},
  year = {2025},
  volume = {1},
  number = {1},
  pages = {1},
  doi = {10.5455/jbph.2025.06}
}
Kostenlos starten →